[2] A 2025 randomised phase 1 trial in adults with overweight or obesity found that tirzepatide reduced overall appetite, food cravings, tendency to overeat, perceived hunger and reactivity to foods in the environment, while not increasing cognitive restraint
Under a constant light intensity, NBT (75 M), methionine (12.5 mM), riboflavin (20 M), and RHEA@Gel were combined for 10 min
Messiahs team published another study using a different database that found weight-loss surgery rates had increased 15% among adolescents and young adults in the U.S
At TrimRx, we are committed to being your partner in this transformation
Hofmeister, R
How do GLP-1 receptor agonists reduce cardiovascular risks in patients with a history of atherosclerotic cardiovascular disease (ASCVD), and why might these benefits be significant for long-term patient care